Selina Chen‐Kiang - Concepedia

Author

Selina Chen‐Kiang

Also Known As

Chen-Kiang, Selina, Morse, Leslie, S Chen-Kiang, S Chen‐Kiang, S. Chen-Kiang, S. Chen‐Kiang, Selina Chen-Kiang, Selina Chen‐Kiang, Selina Y. Chen-Kiang, Su, Lishan

285

Publications

10.5K

Citations

H-Index

Concepts

All Affiliations

Cornell University Icahn School of Medicine at Mount Sinai NewYork–Presbyterian Hospital Weill Cornell Medicine New York Hospital Queens

About

Selina Chen‐Kiang is an author at Cornell University specializing in medicine, cell biology, and immunology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	30	44	3.7K
2	Natural Sciences	12	12	692
3	Health Sciences	4	4	92
4	Engineering	2	2	101
5	Allergy	2	2	115

Selina Chen‐Kiang

Publications

8.9K

Citations

H-Index

Page 1

	Year	Citations
Requirement of Serine Phosphorylation for Formation of STAT-Promoter Complexes Xiaokui Zhang, John Blenis, Heng‐Chun Li, Science	1995	578
AID Is Required for c-myc/IgH Chromosome Translocations In Vivo Almudena R. Ramiro, Mila Janković, Thomas Eisenreich, Cell HistocompatibilityChromatinC-myc/igh Chromosome TranslocationsCytogeneticsChromosomal Rearrangement	2004	453
Attenuation of Apoptosis Underlies B Lymphocyte Stimulator Enhancement of Humoral Immune Response Eunice N. Hatada, Hayyoung Lee, Michelle R. Tourigny, The Journal of Experimental Medicine InflammationB Cell ProliferationAutoimmune DiseaseHumoral Immune ResponseB Cell Repertoire	2000	424
CDK inhibitors p18<sup>INK4c</sup> and p27<sup>Kip1</sup> mediate two separate pathways to collaboratively suppress pituitary tumorigenesis David S. Franklin, Virginia Godfrey, Hayyoung Lee, Genes & Development	1998	409
Outcome of Deferred Initial Therapy in Mantle-Cell Lymphoma Peter Martin, Amy Chadburn, Paul J. Christos, Journal of Clinical Oncology	2009	335
Selective CDK4/6 inhibition with tumor responses by PD0332991 in patients with mantle cell lymphoma John P. Leonard, Ann S. LaCasce, Mitchell R. Smith, Blood	2012	291
Postibrutinib outcomes in patients with mantle cell lymphoma Peter Martin, Kami J. Maddocks, John P. Leonard, Blood	2016	275
RETRACTED: Coordinated Silencing of MYC-Mediated miR-29 by HDAC3 and EZH2 as a Therapeutic Target of Histone Modification in Aggressive B-Cell Lymphomas Xinwei Zhang, Xiaohong Zhao, Warren Fiskus, Cancer Cell Hematological MalignancyTumor BiologyLymphoid NeoplasiaMedicineImmunology	2012	273
Cell-Cycle Reprogramming for PI3K Inhibition Overrides a Relapse-Specific C481S <i>BTK</i> Mutation Revealed by Longitudinal Functional Genomics in Mantle Cell Lymphoma David Chiron, Maurizio Di Liberto, Peter Martin, Cancer Discovery	2014	271
A Novel Orally Active Small Molecule Potently Induces G1 Arrest in Primary Myeloma Cells and Prevents Tumor Growth by Specific Inhibition of Cyclin-Dependent Kinase 4/6 Linda B. Baughn, Maurizio Di Liberto, Kaida Wu, Cancer Research	2006	222

Page 1